1081 Burrard Street
Dana Nohynek, MSc, RAC
Director, Regulatory Affairs and Quality Assurance, CHÉOS
Overview of Risk Management
The 2016 ICH E6 (R2) Addendum to Good Clinical Practice guideline requires clinical trial sponsors to incorporate a risk management plan as part of clinical trial activities. Risk Management allows the study team to identify areas where issues may occur in a clinical study, and incorporate strategies to prevent issues from impacting the study’s successful completion.
The Lunch and Learn Series is a recurring educational series aimed at research coordinators. Each meeting is generally eligible for continuing education credit through SoCRA.
See the Lunch and Learn page for upcoming speakers and topics